Skip to main content
Publish date:

Trubion Edges Higher

The company sells 4 million shares in its IPO.

Trubion Pharmaceuticals (TRBN) priced its initial public offering of 4 million shares at $13 each.

Concurrent with the offering,



TheStreet Recommends

has agreed to purchase 800,000 shares directly from Trubion.

Trubion was up 5 cents to $13.05.